home / stock / cycc / cycc news


CYCC News and Press, Cyclacel Pharmaceuticals Inc.

Stock Information

Company Name: Cyclacel Pharmaceuticals Inc.
Stock Symbol: CYCC
Market: NASDAQ
Website: cyclacel.com

Menu

Get CYCC Alerts

News, Short Squeeze, Breakout and More Instantly...

CYCC - Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified industries, today announced that it has closed the previously announced transactio...

CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$0.98

2025-08-13 16:31:34 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split Financial information for Cyclacel Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cyclacel Pharmaceuti...

CYCC - Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its second quarter financial results and provided a business update. ...

CYCC - Expected US Company Earnings on Wednesday, August 13th, 2025

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

CYCC - Plogosertib Shows Promise in Biliary Tract Cancer with BUBR1 as Potential Biomarker

2025-08-05 07:41:28 ET DENVER, Colo., Aug 05, 2025 ( 247marketnews.com )- Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported encouraging findings from a recently published independent preclinical study evaluating its PLK1 inhibitor, plogosertib, in biliary tract cancer (BTC) titled Eva...

CYCC - CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing inn...

CYCC - US Companies Moving the Markets, Morning edition
Thu, Jul 24, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) rose 33.7% to $0.0337 on volume of 383,443,665 shares Garden Stage Limited (GSIW) rose 75.2% to $0.308625 on volume of 170,360,248 shares AEye Inc. (LIDR) rose 236.7% to $3.805 on volume of 169,799,740 sh...

CYCC - US Companies Moving the Markets, Evening edition
Fri, Jul 18, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 36.4% to $2.25 on volume of 547,098,005 shares Incannex Healthcare Inc. (IXHL) rose 64.8% to $0.61 on volume of 472,694,351 shares Bit Origin Limited (BTOG) rose 23.6% to $0.78 on volume of 357,677,...

CYCC - CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price volatility. The...

CYCC - Stocks to Watch into the Close and After-Hours: M&A Momo and AI Plays Heating Up

2025-07-15 15:46:30 ET DENVER, Colo., Jul 15, 2025 ( 247marketnews.com )- Today’s afterhours could get spicy for several stocks on our watch list. Like Cyclacel (NASDAQ:CYCC) , which we featured this morning and traded as high as $19.25. Longevity Health (NASDAQ...

Next 10